A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
Ahead of the weekend's fixtures we take a look at what's going on in the Premier League in the region.
Tributes to a teenager who died after suffering from a severe asthma attack will be paid at tonight's Everton match.
The Environment Agency is encouraging landowners to plant areas of woodland to help prevent events like Storm Desmond happening again.